In conclusion, our data suggest that PSMC2 promotes HCC cell proliferation and cycle progression through the p21/cyclin D1 signaling pathway and provide novel evidence supporting the clinical and biological significance of PSMC2 in HCC. Here, PSMC2 is linked to hepatocellular carcinoma.